Ycg LLC reduced its holdings in Colgate-Palmolive (NYSE:CL) by 20.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 446,800 shares of the company’s stock after selling 111,539 shares during the period. Colgate-Palmolive makes up 4.9% of Ycg LLC’s holdings, making the stock its 9th biggest position. Ycg LLC owned 0.05% of Colgate-Palmolive worth $32,844,000 as of its most recent SEC filing.
Several other large investors have also bought and sold shares of CL. Nuveen Asset Management LLC raised its stake in Colgate-Palmolive by 16,117.1% during the second quarter. Nuveen Asset Management LLC now owns 6,435,107 shares of the company’s stock worth $461,204,000 after purchasing an additional 6,395,426 shares during the period. Invesco Ltd. raised its stake in Colgate-Palmolive by 201.8% during the second quarter. Invesco Ltd. now owns 8,642,044 shares of the company’s stock worth $619,374,000 after purchasing an additional 5,778,145 shares during the period. FMR LLC raised its stake in Colgate-Palmolive by 29.1% during the first quarter. FMR LLC now owns 7,384,604 shares of the company’s stock worth $506,141,000 after purchasing an additional 1,665,348 shares during the period. AQR Capital Management LLC raised its stake in Colgate-Palmolive by 52.2% during the second quarter. AQR Capital Management LLC now owns 3,485,442 shares of the company’s stock worth $249,801,000 after purchasing an additional 1,195,074 shares during the period. Finally, Vanguard Group Inc. raised its stake in Colgate-Palmolive by 1.4% during the second quarter. Vanguard Group Inc. now owns 76,502,840 shares of the company’s stock worth $5,482,958,000 after purchasing an additional 1,056,530 shares during the period. 76.06% of the stock is currently owned by hedge funds and other institutional investors.
A number of equities research analysts have weighed in on CL shares. Bank of America set a $80.00 price target on shares of Colgate-Palmolive and gave the company a “buy” rating in a research report on Friday, July 12th. UBS Group lifted their price target on shares of Colgate-Palmolive from $80.00 to $82.00 and gave the stock a “buy” rating in a research note on Monday, July 29th. Morgan Stanley lifted their price target on shares of Colgate-Palmolive from $72.00 to $74.00 and gave the stock an “equal weight” rating in a research note on Monday, July 29th. ValuEngine downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Finally, Deutsche Bank lifted their price target on shares of Colgate-Palmolive from $74.00 to $76.00 and gave the stock a “hold” rating in a research note on Friday, July 12th. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and six have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $73.40.
Shares of NYSE:CL traded down $0.53 on Wednesday, reaching $67.87. 367,031 shares of the company were exchanged, compared to its average volume of 3,243,114. Colgate-Palmolive has a 1-year low of $57.41 and a 1-year high of $76.41. The firm has a market cap of $60.50 billion, a price-to-earnings ratio of 22.84, a price-to-earnings-growth ratio of 4.54 and a beta of 0.75. The company has a 50-day moving average of $72.14 and a 200-day moving average of $71.69.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, July 26th. The company reported $0.72 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.72. Colgate-Palmolive had a net margin of 14.77% and a negative return on equity of 10,821.98%. The business had revenue of $3.87 billion for the quarter, compared to analysts’ expectations of $3.88 billion. During the same period in the prior year, the company posted $0.77 EPS. The business’s revenue for the quarter was down .5% on a year-over-year basis. As a group, analysts expect that Colgate-Palmolive will post 2.84 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Wednesday, October 23rd will be paid a dividend of $0.43 per share. The ex-dividend date is Tuesday, October 22nd. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.53%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.91%.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.